Health Boards
Wed-16-11-2016, 20:52 PM
(This post was last modified: Thu-17-11-2016, 07:17 AM by Caroline.
Edit Reason: Changing readability.
)
I now have read this one better.
LAS41008 is a development of Almirall, a spanish pharmacist .... In the Netherlands this is seen as the coming competitor of Psorinovo, at least that are the rumours. It is said that this also has a slow release principle, just like Psorinovo and Tecfidera. But that still is not sure, we will have to wait for the market release. If internationally released it may be able to kick out fumaderm and also Psorinovo. We'll see........
LAS41008 is a development of Almirall, a spanish pharmacist .... In the Netherlands this is seen as the coming competitor of Psorinovo, at least that are the rumours. It is said that this also has a slow release principle, just like Psorinovo and Tecfidera. But that still is not sure, we will have to wait for the market release. If internationally released it may be able to kick out fumaderm and also Psorinovo. We'll see........
